Among many candidates, TNF and EGF are predicted AMD risk genes1,45,46 and progression factors47,48, and while some studies suggest elevated gene/protein levels in AMD and other pathologies39–42,44,48,49, none of this has been validated yet in larger patient studies or is considered a high priority (Supplementary Data 1). This evidence concerns the gene TNF and age-related macular degeneration.